Global In–Vitro Diagnostics (IVDs) Medical Device Market Growth 2024-2030
In-Vitro Diagnostics, valued at US$ 102.85 billion in 2023, are forecasted to reach US$ 146.53 billion by 2030, with a 5.2% CAGR due to increasing demand in the downstream market.
- Bonafide Trust
- 04-01-2024
- Pages : 147
- Figures : 81
- Tables : 177
- Region : Global
- Category : Lifescience
- Medical Devices
According to Publisher’s latest study, the global In-Vitro Diagnostics Medical Device market size was valued at US$ 102850 million in 2023. With the growing demand in the downstream market, In-Vitro Diagnostics is forecast to a readjusted size of US$ 146530 million by 2030 with a CAGR of 5.2% during the review period.
The research report highlights the growth potential of the global In-Vitro Diagnostics market. In-Vitro Diagnostics is expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimisation remain crucial for the widespread adoption of In-Vitro Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalise on the immense opportunities presented by the In-Vitro Diagnostics market. In-vitro diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagents.
Key Features:
The report on the In-Vitro Diagnostics market reflects various aspects and provides valuable insights into the industry.
Market Size and Growth: The research report provides an overview of the current size and growth of the In-Vitro Diagnostics market. It may include historical data, market segmentation by Type (e.g., Tissue Diagnostics, Professional Diagnostic), and regional breakdowns.
Market Drivers: Growing Disease Burden: The need for diagnostic testing and screening techniques is driven by the rising incidence of infectious outbreaks, chronic diseases, and ailments connected to lifestyle choices. The demand for early illness identification and proactive management is expanding due to ageing populations and changing epidemiological trends, which is driving the development of IVD technology. Technological Developments: The field of IVD is undergoing a revolution thanks to developments in biomarker identification, genomics, proteomics, and digital health technologies. Improved sensitivity, specificity, and multiplexing capabilities of advanced diagnostic platforms allow for quick and precise diagnosis in a variety of disease areas. Transition to customized Medicine: The need for companion diagnostics, pharmacogenomic testing, and molecular profiling services is being driven by the paradigm change towards customized medicine and precision diagnostics. Clinical practice paradigms are reshaped by IVD technologies, which are essential in directing treatment decisions, optimizing therapeutic outcomes, and avoiding adverse effects.
Challenges: Exorbitant Instrument Costs to Limit Market Expansion in Developing Nations
Over the past ten years, there have been major changes and enhancements in in-vitro diagnostics goods concerning additional design improvements. However, the high expenses of these instruments and their upkeep limited the market's expansion in some ways. Additionally, only qualified specialists are permitted to use in vitro diagnostics equipment. Additionally, this raises the devices' maintenance costs, which eventually hinders the market's overall growth.
Regulatory Obstacles: Compulsory regulations that differ by location make it difficult to enter a market and get a product approved. For market participants, navigating intricate regulatory frameworks, gaining required certifications, and guaranteeing adherence to quality standards are crucial factors.
Cost Containment Pressures: The need to prove the clinical utility and cost-effectiveness of IVD technologies is growing as healthcare systems struggle with rising expenses and tight budgets. Market participants must match their strategy for product pricing with the value judgments of healthcare stakeholders and outcomes-based reimbursement schemes.
Data Privacy and Security Issues: As digital health solutions and connected medical equipment proliferate, data privacy, security lapses, and regulatory compliance become more pressing problems. Building confidence and promoting the adoption of IVD technology requires securing patient health information, guaranteeing interoperability, and abiding by data protection laws.
Technological Developments: The research report can delve into the latest technological developments in the In-Vitro Diagnostics industry. This includes advancements in In-Vitro Diagnostics technology, In-Vitro Diagnostics new entrants, In-Vitro Diagnostics new investment, and other innovations that are shaping the future of In-Vitro Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the In-Vitro Diagnostics market. It includes factors influencing customers' purchasing decisions, and preferences for In-Vitro Diagnostics products.
Government Policies and Incentives: The research report analyses the impact of government policies and incentives on the In-Vitro Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting the In-Vitro Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assesses the environmental impact and sustainability aspects of the In-Vitro Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provides market forecasts and outlook for the In-Vitro Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report concludes with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalise on emerging trends, overcome challenges, and contribute to the growth and development of the In-Vitro Diagnostics market.
Recent developments- NeoGenomics, Inc. is a prominent provider of oncology testing and global contract research services. In March 2023, the company announced that multiple next-generation sequencing (NGS) tests, including Neo Comprehensive - Solid Tumor, a comprehensive genomic profile (CGP) for solid tumour cancers, and Neo Comprehensive - Myeloid Disorders, a CGP for myeloid neoplasms, would be made commercially available.
Market Segmentation:
The In-vitro diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
1. Segmentation by type
• Tissue Diagnostics
• Professional Diagnostic
• Molecular Diagnostic
• Diabetes Monitoring
• Other
2. Segmentation by application
• Diabetes
• Infectious Diseases
• Oncology
• Cardiology
• HIV
• Other
Regional Insights: The market size for in vitro diagnostics is examined in America, Europe, Asia-Pacific, and Middle East and Africa. The in vitro diagnostics market was dominated by America, which is predicted to continue to be so for the duration of the market prediction.
In vitro diagnostics is predicted to grow at the fastest rate in Asia-Pacific during the forecast period. The presence of populated countries with strong purchasing power, like China and India, is responsible for the rise of the market in this region. Additionally, the market is growing due to the increased demand for personalized treatment and the use of high-tech processing to enhance the manufacture of in vitro diagnostic products. Due to the region's established domestic business presence and expanding industrial infrastructure, Asia-Pacific presents a lucrative opportunity for major players in the in vitro diagnostics market. As a result, it is expected to grow at the fastest rate during the forecast period. In addition, a major factor propelling the IVD market in the Asia-Pacific region is the rise in the prevalence of chronic illnesses including diabetes, heart disease, and cancer. For these disorders to be identified early on, managed, and monitored, diagnostic testing is essential.
America dominates the market which occupies 41.39% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, occupying 15.74% of the whole market.
3. Americas
• United States
• Canada
• Mexico
• Brazil
4. APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
5. Europe
• Germany
• France
• UK
• Italy
• Russia
6. Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries
Competitive Landscape: The concentration of the market is relatively high, and the top 10 companies include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Becton Dickinson, BioMerieux, Sysmex, Hologic, Ortho Clinical Diagnostics, they occupied about 70% of the whole market. The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
• Roche
• Abbott
• Danaher
• Siemens Healthineers
• Thermo Fisher Scientific
• Sysmex
• BioMerieux
• Ortho Clinical Diagnostics
• Becton Dickinson
• Bio-Rad Laboratories
• Hologic
• LifeScan
• Qiagen
• Wuhan Easy Diagnosis
• Wondfo
• KHB
• Hotgen
• Mindray
• Sinocare
• Getein Biotech
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global In–Vitro Diagnostics (IVDs) Medical Device Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for In–Vitro Diagnostics (IVDs) Medical Device by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for In–Vitro Diagnostics (IVDs) Medical Device by Country/Region, 2019, 2023 & 2030
- 2.2 In–Vitro Diagnostics (IVDs) Medical Device Segment by Type
- 2.2.1 Consumables
- 2.2.2 Instruments
- 2.3 In–Vitro Diagnostics (IVDs) Medical Device Sales by Type
- 2.3.1 Global In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Type (2019-2024)
- 2.3.2 Global In–Vitro Diagnostics (IVDs) Medical Device Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global In–Vitro Diagnostics (IVDs) Medical Device Sale Price by Type (2019-2024)
- 2.4 In–Vitro Diagnostics (IVDs) Medical Device Segment by Application
- 2.4.1 Hospital
- 2.4.2 Laboratory
- 2.4.3 Household
- 2.5 In–Vitro Diagnostics (IVDs) Medical Device Sales by Application
- 2.5.1 Global In–Vitro Diagnostics (IVDs) Medical Device Sale Market Share by Application (2019-2024)
- 2.5.2 Global In–Vitro Diagnostics (IVDs) Medical Device Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global In–Vitro Diagnostics (IVDs) Medical Device Sale Price by Application (2019-2024)
- 3 Global In–Vitro Diagnostics (IVDs) Medical Device by Company
- 3.1 Global In–Vitro Diagnostics (IVDs) Medical Device Breakdown Data by Company
- 3.1.1 Global In–Vitro Diagnostics (IVDs) Medical Device Annual Sales by Company (2019-2024)
- 3.1.2 Global In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Company (2019-2024)
- 3.2 Global In–Vitro Diagnostics (IVDs) Medical Device Annual Revenue by Company (2019-2024)
- 3.2.1 Global In–Vitro Diagnostics (IVDs) Medical Device Revenue by Company (2019-2024)
- 3.2.2 Global In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Company (2019-2024)
- 3.3 Global In–Vitro Diagnostics (IVDs) Medical Device Sale Price by Company
- 3.4 Key Manufacturers In–Vitro Diagnostics (IVDs) Medical Device Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers In–Vitro Diagnostics (IVDs) Medical Device Product Location Distribution
- 3.4.2 Players In–Vitro Diagnostics (IVDs) Medical Device Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for In–Vitro Diagnostics (IVDs) Medical Device by Geographic Region
- 4.1 World Historic In–Vitro Diagnostics (IVDs) Medical Device Market Size by Geographic Region (2019-2024)
- 4.1.1 Global In–Vitro Diagnostics (IVDs) Medical Device Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global In–Vitro Diagnostics (IVDs) Medical Device Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic In–Vitro Diagnostics (IVDs) Medical Device Market Size by Country/Region (2019-2024)
- 4.2.1 Global In–Vitro Diagnostics (IVDs) Medical Device Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global In–Vitro Diagnostics (IVDs) Medical Device Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas In–Vitro Diagnostics (IVDs) Medical Device Sales Growth
- 4.4 APAC In–Vitro Diagnostics (IVDs) Medical Device Sales Growth
- 4.5 Europe In–Vitro Diagnostics (IVDs) Medical Device Sales Growth
- 4.6 Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Sales Growth
- 5 Americas
- 5.1 Americas In–Vitro Diagnostics (IVDs) Medical Device Sales by Country
- 5.1.1 Americas In–Vitro Diagnostics (IVDs) Medical Device Sales by Country (2019-2024)
- 5.1.2 Americas In–Vitro Diagnostics (IVDs) Medical Device Revenue by Country (2019-2024)
- 5.2 Americas In–Vitro Diagnostics (IVDs) Medical Device Sales by Type
- 5.3 Americas In–Vitro Diagnostics (IVDs) Medical Device Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC In–Vitro Diagnostics (IVDs) Medical Device Sales by Region
- 6.1.1 APAC In–Vitro Diagnostics (IVDs) Medical Device Sales by Region (2019-2024)
- 6.1.2 APAC In–Vitro Diagnostics (IVDs) Medical Device Revenue by Region (2019-2024)
- 6.2 APAC In–Vitro Diagnostics (IVDs) Medical Device Sales by Type
- 6.3 APAC In–Vitro Diagnostics (IVDs) Medical Device Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe In–Vitro Diagnostics (IVDs) Medical Device by Country
- 7.1.1 Europe In–Vitro Diagnostics (IVDs) Medical Device Sales by Country (2019-2024)
- 7.1.2 Europe In–Vitro Diagnostics (IVDs) Medical Device Revenue by Country (2019-2024)
- 7.2 Europe In–Vitro Diagnostics (IVDs) Medical Device Sales by Type
- 7.3 Europe In–Vitro Diagnostics (IVDs) Medical Device Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device by Country
- 8.1.1 Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Revenue by Country (2019-2024)
- 8.2 Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Sales by Type
- 8.3 Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of In–Vitro Diagnostics (IVDs) Medical Device
- 10.3 Manufacturing Process Analysis of In–Vitro Diagnostics (IVDs) Medical Device
- 10.4 Industry Chain Structure of In–Vitro Diagnostics (IVDs) Medical Device
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 In–Vitro Diagnostics (IVDs) Medical Device Distributors
- 11.3 In–Vitro Diagnostics (IVDs) Medical Device Customer
- 12 World Forecast Review for In–Vitro Diagnostics (IVDs) Medical Device by Geographic Region
- 12.1 Global In–Vitro Diagnostics (IVDs) Medical Device Market Size Forecast by Region
- 12.1.1 Global In–Vitro Diagnostics (IVDs) Medical Device Forecast by Region (2025-2030)
- 12.1.2 Global In–Vitro Diagnostics (IVDs) Medical Device Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global In–Vitro Diagnostics (IVDs) Medical Device Forecast by Type
- 12.7 Global In–Vitro Diagnostics (IVDs) Medical Device Forecast by Application
- 13 Key Players Analysis
- 13.1 Roche
- 13.1.1 Roche Company Information
- 13.1.2 Roche In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.1.3 Roche In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 Roche Main Business Overview
- 13.1.5 Roche Latest Developments
- 13.2 Abbott
- 13.2.1 Abbott Company Information
- 13.2.2 Abbott In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.2.3 Abbott In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 Abbott Main Business Overview
- 13.2.5 Abbott Latest Developments
- 13.3 Danaher
- 13.3.1 Danaher Company Information
- 13.3.2 Danaher In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.3.3 Danaher In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 Danaher Main Business Overview
- 13.3.5 Danaher Latest Developments
- 13.4 Siemens Healthineers
- 13.4.1 Siemens Healthineers Company Information
- 13.4.2 Siemens Healthineers In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.4.3 Siemens Healthineers In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Siemens Healthineers Main Business Overview
- 13.4.5 Siemens Healthineers Latest Developments
- 13.5 Thermo Fisher Scientific
- 13.5.1 Thermo Fisher Scientific Company Information
- 13.5.2 Thermo Fisher Scientific In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.5.3 Thermo Fisher Scientific In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 Thermo Fisher Scientific Main Business Overview
- 13.5.5 Thermo Fisher Scientific Latest Developments
- 13.6 Sysmex
- 13.6.1 Sysmex Company Information
- 13.6.2 Sysmex In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.6.3 Sysmex In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 Sysmex Main Business Overview
- 13.6.5 Sysmex Latest Developments
- 13.7 BioMerieux
- 13.7.1 BioMerieux Company Information
- 13.7.2 BioMerieux In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.7.3 BioMerieux In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 BioMerieux Main Business Overview
- 13.7.5 BioMerieux Latest Developments
- 13.8 Ortho Clinical Diagnostics
- 13.8.1 Ortho Clinical Diagnostics Company Information
- 13.8.2 Ortho Clinical Diagnostics In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.8.3 Ortho Clinical Diagnostics In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 Ortho Clinical Diagnostics Main Business Overview
- 13.8.5 Ortho Clinical Diagnostics Latest Developments
- 13.9 Becton Dickinson
- 13.9.1 Becton Dickinson Company Information
- 13.9.2 Becton Dickinson In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.9.3 Becton Dickinson In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 Becton Dickinson Main Business Overview
- 13.9.5 Becton Dickinson Latest Developments
- 13.10 Bio-Rad Laboratories
- 13.10.1 Bio-Rad Laboratories Company Information
- 13.10.2 Bio-Rad Laboratories In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.10.3 Bio-Rad Laboratories In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 Bio-Rad Laboratories Main Business Overview
- 13.10.5 Bio-Rad Laboratories Latest Developments
- 13.11 Hologic
- 13.11.1 Hologic Company Information
- 13.11.2 Hologic In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.11.3 Hologic In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 Hologic Main Business Overview
- 13.11.5 Hologic Latest Developments
- 13.12 LifeScan
- 13.12.1 LifeScan Company Information
- 13.12.2 LifeScan In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.12.3 LifeScan In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.12.4 LifeScan Main Business Overview
- 13.12.5 LifeScan Latest Developments
- 13.13 Qiagen
- 13.13.1 Qiagen Company Information
- 13.13.2 Qiagen In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.13.3 Qiagen In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.13.4 Qiagen Main Business Overview
- 13.13.5 Qiagen Latest Developments
- 13.14 Wuhan Easy Diagnosis
- 13.14.1 Wuhan Easy Diagnosis Company Information
- 13.14.2 Wuhan Easy Diagnosis In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.14.3 Wuhan Easy Diagnosis In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.14.4 Wuhan Easy Diagnosis Main Business Overview
- 13.14.5 Wuhan Easy Diagnosis Latest Developments
- 13.15 Wondfo
- 13.15.1 Wondfo Company Information
- 13.15.2 Wondfo In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.15.3 Wondfo In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.15.4 Wondfo Main Business Overview
- 13.15.5 Wondfo Latest Developments
- 13.16 KHB
- 13.16.1 KHB Company Information
- 13.16.2 KHB In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.16.3 KHB In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.16.4 KHB Main Business Overview
- 13.16.5 KHB Latest Developments
- 13.17 Hotgen
- 13.17.1 Hotgen Company Information
- 13.17.2 Hotgen In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.17.3 Hotgen In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.17.4 Hotgen Main Business Overview
- 13.17.5 Hotgen Latest Developments
- 13.18 Mindray
- 13.18.1 Mindray Company Information
- 13.18.2 Mindray In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.18.3 Mindray In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.18.4 Mindray Main Business Overview
- 13.18.5 Mindray Latest Developments
- 13.19 Sinocare
- 13.19.1 Sinocare Company Information
- 13.19.2 Sinocare In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.19.3 Sinocare In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.19.4 Sinocare Main Business Overview
- 13.19.5 Sinocare Latest Developments
- 13.20 Getein Biotech
- 13.20.1 Getein Biotech Company Information
- 13.20.2 Getein Biotech In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
- 13.20.3 Getein Biotech In–Vitro Diagnostics (IVDs) Medical Device Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.20.4 Getein Biotech Main Business Overview
- 13.20.5 Getein Biotech Latest Developments
- 14 Research Findings and Conclusion
Table 1. In–Vitro Diagnostics (IVDs) Medical Device Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. In–Vitro Diagnostics (IVDs) Medical Device Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Consumables
Table 4. Major Players of Instruments
Table 5. Global In–Vitro Diagnostics (IVDs) Medical Device Sales by Type (2019-2024) & (K Units)
Table 6. Global In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Type (2019-2024)
Table 7. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue by Type (2019-2024) & ($ million)
Table 8. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Type (2019-2024)
Table 9. Global In–Vitro Diagnostics (IVDs) Medical Device Sale Price by Type (2019-2024) & (US$/K Unit)
Table 10. Global In–Vitro Diagnostics (IVDs) Medical Device Sales by Application (2019-2024) & (K Units)
Table 11. Global In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Application (2019-2024)
Table 12. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue by Application (2019-2024)
Table 13. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Application (2019-2024)
Table 14. Global In–Vitro Diagnostics (IVDs) Medical Device Sale Price by Application (2019-2024) & (US$/K Unit)
Table 15. Global In–Vitro Diagnostics (IVDs) Medical Device Sales by Company (2019-2024) & (K Units)
Table 16. Global In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Company (2019-2024)
Table 17. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue by Company (2019-2024) ($ Millions)
Table 18. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Company (2019-2024)
Table 19. Global In–Vitro Diagnostics (IVDs) Medical Device Sale Price by Company (2019-2024) & (US$/K Unit)
Table 20. Key Manufacturers In–Vitro Diagnostics (IVDs) Medical Device Producing Area Distribution and Sales Area
Table 21. Players In–Vitro Diagnostics (IVDs) Medical Device Products Offered
Table 22. In–Vitro Diagnostics (IVDs) Medical Device Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global In–Vitro Diagnostics (IVDs) Medical Device Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share Geographic Region (2019-2024)
Table 27. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global In–Vitro Diagnostics (IVDs) Medical Device Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Country/Region (2019-2024)
Table 31. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas In–Vitro Diagnostics (IVDs) Medical Device Sales by Country (2019-2024) & (K Units)
Table 34. Americas In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Country (2019-2024)
Table 35. Americas In–Vitro Diagnostics (IVDs) Medical Device Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Country (2019-2024)
Table 37. Americas In–Vitro Diagnostics (IVDs) Medical Device Sales by Type (2019-2024) & (K Units)
Table 38. Americas In–Vitro Diagnostics (IVDs) Medical Device Sales by Application (2019-2024) & (K Units)
Table 39. APAC In–Vitro Diagnostics (IVDs) Medical Device Sales by Region (2019-2024) & (K Units)
Table 40. APAC In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Region (2019-2024)
Table 41. APAC In–Vitro Diagnostics (IVDs) Medical Device Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Region (2019-2024)
Table 43. APAC In–Vitro Diagnostics (IVDs) Medical Device Sales by Type (2019-2024) & (K Units)
Table 44. APAC In–Vitro Diagnostics (IVDs) Medical Device Sales by Application (2019-2024) & (K Units)
Table 45. Europe In–Vitro Diagnostics (IVDs) Medical Device Sales by Country (2019-2024) & (K Units)
Table 46. Europe In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Country (2019-2024)
Table 47. Europe In–Vitro Diagnostics (IVDs) Medical Device Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Country (2019-2024)
Table 49. Europe In–Vitro Diagnostics (IVDs) Medical Device Sales by Type (2019-2024) & (K Units)
Table 50. Europe In–Vitro Diagnostics (IVDs) Medical Device Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of In–Vitro Diagnostics (IVDs) Medical Device
Table 58. Key Market Challenges & Risks of In–Vitro Diagnostics (IVDs) Medical Device
Table 59. Key Industry Trends of In–Vitro Diagnostics (IVDs) Medical Device
Table 60. In–Vitro Diagnostics (IVDs) Medical Device Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. In–Vitro Diagnostics (IVDs) Medical Device Distributors List
Table 63. In–Vitro Diagnostics (IVDs) Medical Device Customer List
Table 64. Global In–Vitro Diagnostics (IVDs) Medical Device Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas In–Vitro Diagnostics (IVDs) Medical Device Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas In–Vitro Diagnostics (IVDs) Medical Device Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC In–Vitro Diagnostics (IVDs) Medical Device Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC In–Vitro Diagnostics (IVDs) Medical Device Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe In–Vitro Diagnostics (IVDs) Medical Device Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe In–Vitro Diagnostics (IVDs) Medical Device Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa In–Vitro Diagnostics (IVDs) Medical Device Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global In–Vitro Diagnostics (IVDs) Medical Device Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global In–Vitro Diagnostics (IVDs) Medical Device Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global In–Vitro Diagnostics (IVDs) Medical Device Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Roche Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 80. Roche In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Abbott Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 84. Abbott In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 85. Abbott In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 86. Abbott Main Business
Table 87. Abbott Latest Developments
Table 88. Danaher Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 89. Danaher In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 90. Danaher In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 91. Danaher Main Business
Table 92. Danaher Latest Developments
Table 93. Siemens Healthineers Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Siemens Healthineers In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 95. Siemens Healthineers In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 96. Siemens Healthineers Main Business
Table 97. Siemens Healthineers Latest Developments
Table 98. Thermo Fisher Scientific Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Thermo Fisher Scientific In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 100. Thermo Fisher Scientific In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 101. Thermo Fisher Scientific Main Business
Table 102. Thermo Fisher Scientific Latest Developments
Table 103. Sysmex Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Sysmex In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 105. Sysmex In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 106. Sysmex Main Business
Table 107. Sysmex Latest Developments
Table 108. BioMerieux Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 109. BioMerieux In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 110. BioMerieux In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 111. BioMerieux Main Business
Table 112. BioMerieux Latest Developments
Table 113. Ortho Clinical Diagnostics Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Ortho Clinical Diagnostics In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 115. Ortho Clinical Diagnostics In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 116. Ortho Clinical Diagnostics Main Business
Table 117. Ortho Clinical Diagnostics Latest Developments
Table 118. Becton Dickinson Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Becton Dickinson In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 120. Becton Dickinson In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 121. Becton Dickinson Main Business
Table 122. Becton Dickinson Latest Developments
Table 123. Bio-Rad Laboratories Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Bio-Rad Laboratories In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 125. Bio-Rad Laboratories In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 126. Bio-Rad Laboratories Main Business
Table 127. Bio-Rad Laboratories Latest Developments
Table 128. Hologic Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 129. Hologic In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 130. Hologic In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 131. Hologic Main Business
Table 132. Hologic Latest Developments
Table 133. LifeScan Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 134. LifeScan In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 135. LifeScan In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 136. LifeScan Main Business
Table 137. LifeScan Latest Developments
Table 138. Qiagen Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 139. Qiagen In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 140. Qiagen In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 141. Qiagen Main Business
Table 142. Qiagen Latest Developments
Table 143. Wuhan Easy Diagnosis Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 144. Wuhan Easy Diagnosis In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 145. Wuhan Easy Diagnosis In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 146. Wuhan Easy Diagnosis Main Business
Table 147. Wuhan Easy Diagnosis Latest Developments
Table 148. Wondfo Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 149. Wondfo In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 150. Wondfo In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 151. Wondfo Main Business
Table 152. Wondfo Latest Developments
Table 153. KHB Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 154. KHB In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 155. KHB In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 156. KHB Main Business
Table 157. KHB Latest Developments
Table 158. Hotgen Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 159. Hotgen In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 160. Hotgen In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 161. Hotgen Main Business
Table 162. Hotgen Latest Developments
Table 163. Mindray Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 164. Mindray In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 165. Mindray In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 166. Mindray Main Business
Table 167. Mindray Latest Developments
Table 168. Sinocare Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 169. Sinocare In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 170. Sinocare In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 171. Sinocare Main Business
Table 172. Sinocare Latest Developments
Table 173. Getein Biotech Basic Information, In–Vitro Diagnostics (IVDs) Medical Device Manufacturing Base, Sales Area and Its Competitors
Table 174. Getein Biotech In–Vitro Diagnostics (IVDs) Medical Device Product Portfolios and Specifications
Table 175. Getein Biotech In–Vitro Diagnostics (IVDs) Medical Device Sales (K Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2019-2024)
Table 176. Getein Biotech Main Business
Table 177. Getein Biotech Latest Developments
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (13 December, 2024)
- Notify To Team (13 December, 2024)
- Report updation (14 December, 2024)
- Report Quality Check (14 December, 2024)
- Report Dispatch (15 December, 2024)
- Hard Copy
Recently Viewed Products
Global In–Vitro Diagnostics (IVDs) Medical Device Market Growth 2024-2030
We are friendly and approachable, give us a call.